AI-Enabled Acute Kidney Injury Prediction and the Challenge of Prevention - Top-Institutions - MDSpire

AI-Enabled Acute Kidney Injury Prediction and the Challenge of Prevention

  • By

  • Charat Thongprayoon

  • Francesco Pesce

  • Wisit Cheungpasitporn

  • July 10, 2026

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai / Mount Sinai Health System
    Icahn School of Medicine at Mount Sinai / Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Nephrology

  • #2

    UAB–UC San Diego O’Brien Center for Acute Kidney Injury Research
    UAB–UC San Diego O’Brien Center for Acute Kidney Injury Research

    Birmingham, AL

    Key Differentiators

    • Nephrology

  • #3

    West China Hospital of Sichuan University
    West China Hospital of Sichuan University

    Chengdu, Sichuan

    Key Differentiators

    • Nephrology

  • #4

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Nephrology

  • #5

    Medical Information Mart for Intensive Care IV
    Medical Information Mart for Intensive Care IV

    Boston, MA

    Key Differentiators

    • Nephrology

Original Source(s)

AI-Enabled Acute Kidney Injury Prediction and the Challenge of Prevention

  • by Charat Thongprayoon, Francesco Pesce, Wisit Cheungpasitporn

  • July 10, 2026

Related Content

FDA Approves Cefepime-Zidebactam Injection

Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.

More Physicians Enter Politics

Viewpoint explores how more physician-candidates could reshape both public service and public trust in medicine.

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.